Cited by 5,514Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders ResearchNatural Compounds in Disease Treatment

The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.

The Pathogenesis of Rheumatoid Arthritis

McInnes, Iain B., Schett, Georg·2011·New England Journal of Medicine

DOI 10.1056/nejmra1004965

Open this paper in CoChat — free account

Abstract

The increased understanding of the immune mechanisms of rheumatoid arthritis has led to the development of a considerable number of new therapeutic agents that alter the natural history of the disease and reduce mortality.

Integrity signals

Registry

Crossref · 10.1056/nejmra1004965

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis
Schuerwegh, A. J., Ioan‐Facsinay, A., Dorjée, A. L., Roos, J. A. D. M. D., Bajema, I. M., van der Voort, E. I. H., Huizinga, T. W. J., & Toes, R. E. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913054107 · Cited by 94
Retracted
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.138461 · Cited by 4,959
Evolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,653
The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
Gregersen, P. K., Silver, J., & WINCHESTER, R. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301102 · Cited by 2,633
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Cytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. A. (2007) · Nature reviews. Immunology · doi:10.1038/nri2094 · Cited by 2,576
Self-citation
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
(2010) · The Lancet · doi:10.1016/s0140-6736(09)61717-7 · Cited by 2,546
Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis
Rantapää‐Dahlqvist, S., Jong, B. A. W. D., Berglin, E. H., Hallmans, G., Wadell, G., Stenlund, H. C., Sundin, U., & VENROOIJ, W. J. V. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11223 · Cited by 1,946
A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination
Klareskog, L., Stolt, P., Lundberg, K., Källberg, H., Bengtsson, C., Grünewald, J., Rönnelid, J., Harris, H. E., Ulfgren, A., Rantapää‐Dahlqvist, S., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21575 · Cited by 1,516

Show all 100 references

Research works printed but not linked: 5

Scher JU, 2010, Arthritis Rheum, 62, 1390
Szekanecz Z, 2009, Front Biosci (Elite Ed), 1, 44
Aupperle KR, 1998, Am J Pathol, 152, 1091
Gravallese EM, 1998, Am J Pathol, 152, 943
Jacobsson LT, 2005, J Rheumatol, 32, 1213

Sorted by citations

Items 701–800 of 1,011

Toxoplasmosis seroprevalence in rheumatoid arthritis patients: A systematic review and meta-analysis
Hosseininejad, Z., Sharif, M., Sarvi, S., Amouei, A., Hosseini, S. A., Nayeri, T., Anvari, D., Saberi, R., Gohardehi, S., Mizani, A., et al. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006545 · Cited by 70
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents
Carbone, F., Bonaventura, A., Liberale, L., Paolino, S., Torre, F., Dallegri, F., Montecucco, F., & Cutolo, M. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8714-z · Cited by 71
The Microbial Metabolite Trimethylamine N-Oxide Links Vascular Dysfunctions and the Autoimmune Disease Rheumatoid Arthritis
Chan, M. M.-Y., Yang, X., Wang, H., Saaoud, F., Sun, Y., & Fong, D. (2019) · Nutrients · doi:10.3390/nu11081821 · Cited by 68
“In RA, monocytes and neutrophils produce the proinflammatory cytokines tumor necrosis factor (TNF)-α and interleukin (IL)-1β within the locally affected joints, but they may enter the circulation to initiate inflammation of the blood vessels, affecting the arterial walls [122,130] (Figure 2).”
Background
Anti‐TNF treatment during pregnancy and birth outcomes: A population‐based study from Denmark, Finland, and Sweden
Bröms, G., Kieler, H., Ekbom, A., Gissler, M., Hellgren, K. E., Lahesmaa‐Korpinen, A., Pedersen, L. H., Schmitt‐Egenolf, M., Sørensen, H. T., & Granath, F. N. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4930 · Cited by 70
“Tumor necrosis factor (TNF), which is produced by T-cells and macrophages, is a key cytokine in the inflammatory processes of these conditions.(6-8) Accordingly, anti-TNF agents infliximab (IFX), adalimumab (ADA), etanercept (ETA), golimumab (GOL), and certolizumab-pegol (CZP)”
Background
The Natural Compound Notopterol Binds and Targets JAK2/3 to Ameliorate Inflammation and Arthritis
Wang, Q. A., Zhou, X., Yang, L., Zhao, Y., Chew, Z., Xiao, J., Liu, C., Zheng, X. S., Zheng, Y., Shi, Q. W., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108158 · Cited by 71
Serum KL-6, CA19-9, CA125 and CEA are Diagnostic Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease in the Chinese Population
Zheng, M., Lou, A., Zhang, H., Zhu, S., Yang, M., & Lai, W. (2021) · Rheumatology and Therapy · doi:10.1007/s40744-021-00288-x · Cited by 70
Effect of JAK Inhibition on the Induction of Proinflammatory HLA – DR + CD90 + Rheumatoid Arthritis Synovial Fibroblasts by Interferon‐γ
Zhao, S., Grieshaber‐Bouyer, R., Rao, D. A., Kolb, P., Chen, H., Andreeva, I., Tretter, T., Lorenz, H., Watzl, C., Wabnitz, G. H., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41958 · Cited by 69
Total glucosides of paeony inhibits Th1/Th17 cells via decreasing dendritic cells activation in rheumatoid arthritis
Lin, J., Xiao, L., Ouyang, G., Shen, Y., Huo, R., Zhou, Z., Sun, Y., Zhu, X., Zhang, J., Shen, B., et al. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.12.005 · Cited by 70
Digoxin ameliorates autoimmune arthritis via suppression of Th17 differentiation
Lee, J. J., Baek, S.-Y., Lee, J., Lee, J., Lee, D., Park, M., Cho, M., Park, S., & Kwok, S. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.03.017 · Cited by 70
RNA sequencing from human neutrophils reveals distinct transcriptional differences associated with chronic inflammatory states
Jiang, K., Sun, X., Chen, Y., Shen, Y., & Jarvis, J. N. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0128-7 · Cited by 70
Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy
Genovese, M. C., Hsia, E. C., Belkowski, S. M., Chien, C., Masterson, T. J., Thurmond, R. L., Manthey, C. L., Yan, X., Ge, T., Franks, C. F., et al. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.141580 · Cited by 70
microRNA-126 targeting PIK3R2 promotes rheumatoid arthritis synovial fibro-blasts proliferation and resistance to apoptosis by regulating PI3K/AKT pathway
Gao, J., Zhou, X., Kong, R., Ji, L., He, L., & Zhao, D. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.12.015 · Cited by 70
Circulating T helper and T regulatory subsets in untreated early rheumatoid arthritis and healthy control subjects
Pandya, J. M., Lundell, A., Hallström, M., Andersson, K. M., Nordström, I., & Rudin, A. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.5a0116-025r · Cited by 72
Identification of a HERV‐K env surface peptide highly recognized in Rheumatoid Arthritis (RA) patients: a cross‐sectional case–control study
Mameli, G., Erre, G., Caggiu, E., Mura, S., Cossu, D., Bo, M., Cadoni, M., Piras, A., Mundula, N., Colombo, E., et al. (2017) · Clinical and Experimental Immunology · doi:10.1111/cei.12964 · Cited by 56
Biology of GM3 Ganglioside
Inokuchi, J., Inamori, K., Kabayama, K., Nagafuku, M., Uemura, S., Go, S., Suzuki, A., Ohno, I., Kanoh, H., & Shishido, F. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.10.004 · Cited by 68
Inhibition of cyclooxygenase-2 activity in subchondral bone modifies a subtype of osteoarthritis
Tu, M., Yang, M., Yu, N., Zhen, G., Wan, M., Liu, W., Ji, B., Ma, H., Guo, Q., Tong, P., et al. (2019) · Bone Research · doi:10.1038/s41413-019-0071-x · Cited by 69
ASIC1a induces synovial inflammation via the Ca 2+ /NFATc3/ RANTES pathway
Zhang, Y., Qian, X., Yang, X., Niu, R., Song, S., Zhu, F., Zhu, C., Peng, X., & Chen, F. (2019) · Theranostics · doi:10.7150/thno.37200 · Cited by 69
The Joint-Brain Axis: Insights From Rheumatoid Arthritis on the Crosstalk Between Chronic Peripheral Inflammation and the Brain
Süß, P., Rothe, T., Hoffmann, A., Schlachetzki, J. C. M., & Winkler, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.612104 · Cited by 72
Probiotics and Amelioration of Rheumatoid Arthritis: Significant Roles of Lactobacillus casei and Lactobacillus acidophilus
Paul, A. K., Paul, A., Jahan, R., Jannat, K., Bondhon, T. A., Hasan, A., Nissapatorn, V., Pereira, M. D. L., Wilairatana, P., & Rahmatullah, M. (2021) · Microorganisms · doi:10.3390/microorganisms9051070 · Cited by 71
Targeting of fibroblast activation protein in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy
Dorst, D. N., Rijpkema, M., Buitinga, M., Walgreen, B., Helsen, M. M. A., Brennan, E., Klein, C., Laverman, P., Ramming, A., Schmidkonz, C., et al. (2021) · Lara D. Veeken · doi:10.1093/rheumatology/keab664 · Cited by 69
Self-citation
Gene–environment interaction in autoimmune disease
Ellis, J. A., Kemp, A., & Ponsonby, A. (2014) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2014.5 · Cited by 71
Synovial fluid proteome in rheumatoid arthritis
Bhattacharjee, M., Balakrishnan, L., Renuse, S., Advani, J., Goel, R., Sathe, G. J., Prasad, T. S. K., Nair, B. G., Jois, R., Shankar, S., et al. (2016) · Clinical Proteomics · doi:10.1186/s12014-016-9113-1 · Cited by 69
Who’s in charge here? Macrophage colony stimulating factor and granulocyte macrophage colony stimulating factor: Competing factors in macrophage polarization
Trus, E., Basta, S., & Gee, K. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154939 · Cited by 75
Proportions of several types of plasma and urine microparticles are increased in patients with rheumatoid arthritis with active disease
Viñuela‐Berni, V., Doníz-Padilla, L., Figueroa‐Vega, N., Portillo-Salazar, H., Abud‐Mendoza, C., Baranda, L., & González‐Amaro, R. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12598 · Cited by 68
Kcnn4 Is a Regulator of Macrophage Multinucleation in Bone Homeostasis and Inflammatory Disease
Kang, H., Kerloc’h, A., Rotival, M., Xu, X., Zhang, Q., D’Souza, Z., Kim, M. S., Scholz, J. A. C., Ko, J., Srivastava, P. K., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.032 · Cited by 69
Anti-inflammatory and Pro-apoptotic Effects of 18beta-Glycyrrhetinic Acid In Vitro and In Vivo Models of Rheumatoid Arthritis
Feng, Y., Mei, L., Wang, M., Huang, Q., & Huang, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.681525 · Cited by 68
Single-cell RNA sequencing in orthopedic research
Wang, T., Wang, L., Zhang, L., Long, Y., Zhang, Y., & Hou, Z. (2023) · Bone Research · doi:10.1038/s41413-023-00245-0 · Cited by 68
Ursolic acid ameliorates autoimmune arthritis via suppression of Th17 and B cell differentiation
Baek, S.-Y., Lee, J., Lee, D.-G., Park, M., Lee, J. J., Kwok, S., Cho, M., & Park, S. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.58 · Cited by 68
Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation
Jones, D. S., Jenney, A., Swantek, J. L., Burke, J. M., Lauffenburger, D. A., & Sorger, P. K. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2211 · Cited by 68
Circulating cell free DNA: a marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis
Hashimoto, T., Yoshida, K., Hashimoto, N., Nakai, A., Kaneshiro, K., Suzuki, K., Kawasaki, Y., Shibanuma, N., & Hashiramoto, A. (2016) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12959 · Cited by 68
B cells and their cytokine activities implications in human diseases
Fillatreau, S. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.07.020 · Cited by 71
Histone demethylase JMJD3 regulates fibroblast‐like synoviocyte‐mediated proliferation and joint destruction in rheumatoid arthritis
Jia, W., Wu, W., Yang, D., Xiao, C., Su, Z., Huang, Z., Li, Z., Qin, M., Huang, M., Liu, S., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201701483r · Cited by 70
Upadacitinib for the treatment of rheumatoid arthritis
Serhal, L., & Edwards, C. J. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1544892 · Cited by 68
“IL-1, IL-6, and TNF represent key pro-inflammatory cytokines in RA [24].”
Background
Celecoxib for rheumatoid arthritis
Fidahić, M., Kadić, A. J., Radić, M., & Puljak, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012095.pub2 · Cited by 68
Methotrexate Normalizes Up‐Regulated Folate Pathway Genes in Rheumatoid Arthritis
Blits, M., Jansen, G., Assaraf, Y. G., van de Wiel, M. A., Lems, W. F., Nurmohamed, M. T., van Schaardenburg, D., Voskuyl, A. E., Wolbink, G., Vosslamber, S., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38094 · Cited by 67
HMGB1–LPS complex promotes transformation of osteoarthritis synovial fibroblasts to a rheumatoid arthritis synovial fibroblast-like phenotype
Qin, Y., Chen, Y., Wang, W., Wang, Z., Tang, G., Zhang, P., He, Z., Liu, Y., Dai, S.-M., & Shen, Q. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.48 · Cited by 69
Stromal cell-derived factor-1 (CXCL12) and its role in bone and muscle biology
Gilbert, W. B., Bragg, R., Elmansi, A. M., McGee‐Lawrence, M. E., Isales, C. M., Hamrick, M. W., Hill, W., & Fulzele, S. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154783 · Cited by 67
Mesenchymal stem cell-originated exosomal lncRNA HAND2-AS1 impairs rheumatoid arthritis fibroblast-like synoviocyte activation through miR-143-3p/TNFAIP3/NF-κB pathway
Su, Y., Liu, Y., Ma, C., Guan, C., Ma, X., & Meng, S. (2021) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-021-02248-1 · Cited by 67
A multidisciplinary lifestyle program for rheumatoid arthritis: the ‘Plants for Joints’ randomized controlled trial
Walrabenstein, W., Wagenaar, C. A., van der Leeden, M., Turkstra, F., Twisk, J. W. R., Boers, M., van Middendorp, H., Weijs, P. J. M., & van Schaardenburg, D. (2023) · Rheumatology · doi:10.1093/rheumatology/keac693 · Cited by 75
“RA is a chronic systemic inflammatory disease, which manifests primarily as polyarthritis [1].”
Background
Tocilizumab, A Humanized Anti-IL-6R Antibody, as an Emerging Therapeutic Option for Rheumatoid Arthritis: Molecular and Cellular Mechanistic Insights
Hashizume, M., Tan, S., Takano, J., Ohsawa, K., Hasada, I., Hanasaki, A., Ito, I., Mihara, M., & Nishida, K. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2014.938325 · Cited by 68
Integrated Enrichment Analysis of Variants and Pathways in Genome-Wide Association Studies Indicates Central Role for IL-2 Signaling Genes in Type 1 Diabetes, and Cytokine Signaling Genes in Crohn's Disease
Carbonetto, P. S., & Stephens, M. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003770 · Cited by 68
An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression
Mil, A. H. M. V. D. H., Knevel, R., Cavet, G., Huizinga, T. W. J., & Haney, D. J. (2013) · Lara D. Veeken · doi:10.1093/rheumatology/kes378 · Cited by 67
Increased expression of long noncoding RNAs LOC100652951 and LOC100506036 in T cells from patients with rheumatoid arthritis facilitates the inflammatory responses
Lu, M., Yu, H.-C., Yu, C., Huang, H., Koo, M., Tung, C., & Lai, N. (2015) · Immunologic Research · doi:10.1007/s12026-015-8756-8 · Cited by 67
Lysophospholipid Receptors, as Novel Conditional Danger Receptors and Homeostatic Receptors Modulate Inflammation—Novel Paradigm and Therapeutic Potential
Wang, X., Li, Y., Nanayakkara, G., Shao, Y., Liang, B., Cole, L. E., Yang, W. Y., Li, X., Cueto, R., Yu, J., et al. (2016) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-016-9700-6 · Cited by 65
Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis
Meißner, Y., Zink, A., Kekow, J., Rockwitz, K., Liebhaber, A., Zinke, S., Gerhold, K., Richter, A., Listing, J., & Strangfeld, A. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1077-z · Cited by 67
Interleukin-10-producing LAG3+ regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis
Nakachi, S., Sumitomo, S., Tsuchida, Y., Tsuchiya, H., Kono, M., Kato, R., Sakurai, K., Hanata, N., Nagafuchi, Y., Tateishi, S., et al. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1309-x · Cited by 69
Curcumin for the Management of Periodontitis and Early ACPA-Positive Rheumatoid Arthritis: Killing Two Birds with One Stone
Asteriou, E., Gkoutzourelas, A., Mavropoulos, Α., Katsiari, C. G., Sakkas, L. I., & Bogdanos, D. P. (2018) · Nutrients · doi:10.3390/nu10070908 · Cited by 67
Role of myeloid regulatory cells (MRCs) in maintaining tissue homeostasis and promoting tolerance in autoimmunity, inflammatory disease and transplantation
Amodio, G., Cichy, J., Conde, P., Matteoli, G., Moreau, A., Ochando, J., Oral, B. H., Pekarová, M., Ryan, E. J., Roth, J., et al. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2264-3 · Cited by 68
“The role of resident M2 macrophages in maintaining tissue integrity and limiting/resolving inflammation is supported by several lines of evidence both in non-inflamed tissues and experimental models, in which M2 and murine Ly6Clow macrophage depletion results in worsened disease [21].”
The role of microRNA-16 in the pathogenesis of autoimmune diseases: A comprehensive review
Yan, L., Liang, M., Hou, X., Zhang, Y., Zhang, H., Guo, Z., Ji, J., Feng, Z., & Mei, Z. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.01.044 · Cited by 67
The impact of anti-TNFα agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database
Mazhar, F., Battini, V., Gringeri, M., Pozzi, M., Mosini, G., Marran, A. M. N., Akram, S., van Manen, R. P., Radice, S., Clementi, E., et al. (2021) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2021.1948529 · Cited by 67
Effects of Janus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin-6 during treatment for rheumatoid arthritis
Migita, K., Izumi, Y., Jiuchi, Y., Kozuru, H., Kawahara, C., Izumi, M., Sakai, T., Nakamura, M., Motokawa, S., Nakamura, T., et al. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12234 · Cited by 66
Interleukin 26 Skews Macrophage Polarization Towards M1 Phenotype by Activating cJUN and the NF-κB Pathway
Lin, Y., Wang, Y.-H., Peng, Y., Liu, F., Lin, G., Huang, S., Sytwu, H., & Cheng, C.-P. (2020) · Cells · doi:10.3390/cells9040938 · Cited by 66
“Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by many kinds of immune cells infiltrated in articular joints [1].”
Background
Matrix Metalloproteinase-Responsive PEGylated Lipid Nanoparticles for Controlled Drug Delivery in the Treatment of Rheumatoid Arthritis
He, L., Fan, D., Liang, W., Wang, Q., & Fang, J. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00242 · Cited by 68
Cationic Block Copolymer Nanoparticles with Tunable DNA Affinity for Treating Rheumatoid Arthritis
Wu, J., Liang, H., Li, Y., Shi, Y., Bottini, M., Chen, Y., & Liu, L. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000391 · Cited by 66
Reprogramming of synovial macrophage metabolism by synovial fibroblasts under inflammatory conditions
Saeki, N., & Imai, Y. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00678-8 · Cited by 67
Artesunate attenuates bone erosion in rheumatoid arthritis by suppressing reactive oxygen species via activating p62/Nrf2 signaling
Su, X., Guo, W., Yuan, B., Wang, D., Liu, L., Wu, X., Zhang, Y., Kong, X., & Lin, N. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111382 · Cited by 66
Identification of Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor in Rheumatoid Arthritis Using Network Pharmacology and Molecular Docking
Bai, L., Chen, H., Zhou, P., & Yu, J. G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.690118 · Cited by 66
Betulin suppresses TNF-α and IL-1β production in osteoarthritis synovial fibroblasts by inhibiting the MEK/ERK/NF-κB pathway
Su, C., Lin, C., Tsai, C., Lee, H., Lo, L.-C., Huang, W., Wu, Y., Hsieh, C., & Tang, C. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104729 · Cited by 65
Single-cell multimodal analysis identifies common regulatory programs in synovial fibroblasts of rheumatoid arthritis patients and modeled TNF-driven arthritis
Armaka, M., Konstantopoulos, D., Tzaferis, C., Lavigne, M. D., Σάκκου, Μ., Liakos, A., Sfikakis, P. P., Dimopoulos, M. A., Fousteri, M. I., & Kollias, G. A. (2022) · Genome Medicine · doi:10.1186/s13073-022-01081-3 · Cited by 67
Neutrophil extracellular traps mediate bone erosion in rheumatoid arthritis by enhancing RANKL‐induced osteoclastogenesis
Schneider, A. H., Taira, T. M., Públio, G. A., Prado, D. D. S., Yabuta, P. B. D., dos Santos, J. C., Machado, C. C., de Souza, F. F. L., Venturini, L. G. R., de Oliveira, R. D. R., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16227 · Cited by 72
Fructose 1,6-bisphosphate, a high-energy intermediate of glycolysis, attenuates experimental arthritis by activating anti-inflammatory adenosinergic pathway
Veras, F. P., Peres, R. S., Saraiva, A. L., Pinto, L. G., Louzada‐Júnior, P., Cunha, T. M., Paschoal, J. A. R., Cunha, F. Q., & Alves-Filho, J. C. (2015) · Scientific Reports · doi:10.1038/srep15171 · Cited by 66
CCR6 and CCL20: emerging players in the pathogenesis of rheumatoid arthritis
Lee, A. Y. S., & Körner, H. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2013.97 · Cited by 66
Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis
Wang, F., Xu, L., Feng, X., Guo, D., Tan, W., & Zhang, M. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4067 · Cited by 66
Anthocyanin Extracted from Black Soybean Seed Coats Prevents Autoimmune Arthritis by Suppressing the Development of Th17 Cells and Synthesis of Proinflammatory Cytokines by Such Cells, via Inhibition of NF-κB
Min, H. K., Kim, S., Baek, S.-Y., Woo, J., Park, J., Cho, M., Lee, J. J., Kwok, S., Kim, S. W., & Park, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138201 · Cited by 66
miRNA‐Regulated Key Components of Cytokine Signaling Pathways and Inflammation in Rheumatoid Arthritis
Sharma, A. R., Sharma, G., Lee, S., & Chakraborty, C. (2016) · Medicinal Research Reviews · doi:10.1002/med.21384 · Cited by 66
Inflammation as a Risk of Developing Chronic Kidney Disease in Rheumatoid Arthritis
Kochi, M., Kohagura, K., Shiohira, Y., Iseki, K., & Ohya, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160225 · Cited by 66
Pesticide Exposure and Risk of Rheumatoid Arthritis among Licensed Male Pesticide Applicators in the Agricultural Health Study
Meyer, A., Sandler, D. P., Freeman, L. E. B., Hofmann, J. N., & Parks, C. G. (2017) · Environmental Health Perspectives · doi:10.1289/ehp1013 · Cited by 66
Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study
Kameda, H., Takeuchi, T., Yamaoka, K., Oribe, M., Kawano, M., Zhou, Y., Othman, A. A., Pangan, A. L., Kitamura, S., Meerwein, S., et al. (2020) · Lara D. Veeken · doi:10.1093/rheumatology/keaa084 · Cited by 66
MicroRNA-132, miR-146a, and miR-155 as potential biomarkers of methotrexate response in patients with rheumatoid arthritis
Singh, A., Patro, P. S., & Aggarwal, A. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4380-z · Cited by 65
“However, due to complexity in disease pathogenesis, a variable response to each DMARD is seen in patients [3].”
Background
Traditional Chinese Medicine as a Treatment for Rheumatoid Arthritis: From Empirical Practice to Evidence-Based Therapy
Pan, H., Xiao, Y., Wang, W., Ren, R., Leung, E. L., & Liu, L. (2019) · Engineering · doi:10.1016/j.eng.2019.01.018 · Cited by 65
“The pathogenesis of RA has not yet been well defined due to its complicated mechanism, which involves systemic autoimmune manifestations in multiple tissues, organs, and systems [1,2,8,9].”
Background
Involvement of long noncoding RNAs in the pathogenesis of autoimmune diseases
Zou, Y., & Xu, H. (2020) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2020.100044 · Cited by 65
“As one of the most common rheumatic diseases, RA has been a heavy burden to human health because it causes joint destruction and physical disability; however, despite intensive research in the field, the etiology and pathogenesis of RA is not yet fully understood [46].”
Background
Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease
Barnhoorn, M. C., Hakuno, S. K., Bruckner, R. S., Rogler, G., Hawinkels, L. J. A. C., & Scharl, M. M. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa009 · Cited by 67
“In the inflamed joints, leukocytes and a variety of innate effector cells accumulate in the synovium, which is similar to what occurs in the bowel of IBD patients, together with expansion of the already present lining of fibroblast-like synoviocytes [FLSs].(55) Hyperplasia of this specific type of fibroblast, found in…”
Background
The Effect of Vitamin D Supplementation on Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis
Guan, Y., Yang, H., Guan, Y., Bu, H., & Wang, H. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.596007 · Cited by 65
Significantly Improving the Bioefficacy for Rheumatoid Arthritis with Supramolecular Nanoformulations
Ma, C., Li, B., Zhang, J., Sun, Y., Li, J., Zhou, H., Shen, J., Gu, R., Qian, J., Fan, C., et al. (2021) · Advanced Materials · doi:10.1002/adma.202100098 · Cited by 65
Characteristics of traditional Chinese medicine use in patients with rheumatoid arthritis in Taiwan: A nationwide population-based study
Huang, M., Pai, F.-T., Lin, C., Chang, C., Chang, H., Lee, Y., Sun, M.-F., & Yen, H. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.10.024 · Cited by 65
Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study
Trouvin, A., Jacquot, S., Grigioni, S., Curis, E., Dedreux, I., Roucheux, A., Boulard, H., Vittecoq, O., Loët, X. L., Boyer, O., et al. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12481 · Cited by 65
Markers of Treatment Response to Methotrexate in Rheumatoid Arthritis: Where Do We Stand?
Halilova, K. I., Brown, E. E., Morgan, S. L., Bridges, S. L., Hwang, M.-H., Arnett, D. K., & Danila, M. I. (2012) · International Journal of Rheumatology · doi:10.1155/2012/978396 · Cited by 65
Bone anabolic changes progress in psoriatic arthritis patients despite treatment with methotrexate or tumour necrosis factor inhibitors
Finzel, S., Kraus, S., Schmidt, S., Hueber, A. J., Rech, J., Engelke, K., Englbrecht, M., & Schett, G. A. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201580 · Cited by 64
Self-citation
Psychometric properties of three single-item pain scales in patients with rheumatoid arthritis seen during routine clinical care: a comparative perspective on construct validity, reproducibility and internal responsiveness
Sendlbeck, M., Araujo, E. G., Schett, G. A., & Englbrecht, M. (2015) · RMD Open · doi:10.1136/rmdopen-2015-000140 · Cited by 65
Self-citation
Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features
Adegunsoye, A., Oldham, J. M., Demchuk, C., Montner, S. M., Vij, R., & Strek, M. E. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.03.012 · Cited by 65
Anti-citrullinated protein antibodies cause arthritis by cross-reactivity to joint cartilage
Ge, C., Tong, D., Liang, B., Lönnblom, E., Schneider, N., Hagert, C., Viljanen, J., Ayoglu, B., Stawikowska, R., Nilsson, P., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93688 · Cited by 65
Infectious Agents and Inflammation: The Role of Microbiota in Autoimmune Arthritis
Diamanti, A. P., Rosado, M. M., & D’Amelio, R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02696 · Cited by 66
Intestinal microbiome as a novel therapeutic target for local and systemic inflammation
Uchiyama, K., Naito, Y., & Takagi, T. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.03.006 · Cited by 65
The RANKL-RANK Axis: A Bone to Thymus Round Trip
Sobacchi, C., Menale, C., & VILLA, A. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00629 · Cited by 65
“In this condition, the synovium and articular tissues are highly enriched in inflammatory leukocytes, likely due to cell recruitment in the inflamed tissue (119), sustained by resident stromal cells of mesenchymal origin (120).”
Background
Efficacy and Safety of Integrated Traditional Chinese Medicine and Western Medicine on the Treatment of Rheumatoid Arthritis: A Meta‐Analysis
Xing, Q., Fu, L., Yu, Z., & Zhou, X. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/4348709 · Cited by 65
“It is characterized by synovial membrane inﬂammation and hyperplasia, autoantibody production, cartilage and bone destruction, and systemic features [2]. typical symptoms of RA are pain and swelling in the joints of hands and feet, accompanied by morning stiﬀness of the aﬀected joints; large joints…”
Coixol Suppresses NF-κB, MAPK Pathways and NLRP3 Inflammasome Activation in Lipopolysaccharide-Induced RAW 264.7 Cells
Hu, Y., Zhou, Q., Liu, T., & Liu, Z. (2020) · Molecules · doi:10.3390/molecules25040894 · Cited by 64
Icariin alleviates rheumatoid arthritis via regulating miR-223-3p/NLRP3 signalling axis
Wu, Z., Luo, J. F., Shi, X., Zhang, S.-X., Zhu, X., & Guo, J. (2020) · Autoimmunity · doi:10.1080/08916934.2020.1836488 · Cited by 65
“Therefore, it is essential to explore effective treatments for RA [2,5].”
Background
Neuroimmune interactions and osteoarthritis pain: focus on macrophages
Geraghty, T., Winter, D. R., Miller, R. J., Miller, R. E., & Malfait, A. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000892 · Cited by 67
Rheumatoid arthritis associated interstitial lung disease: a review.
Assayag, D., Lee, J. S., & King, T. E. (2014) · PubMed · Cited by 64
Protective effects of fenofibrate and resveratrol in an aggressive model of rheumatoid arthritis in rats
Wahba, M. G. F., Messiha, B. A. S., & Abo‐Saif, A. A. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1125931 · Cited by 64
Acute serum amyloid A is an endogenous TLR2 ligand that mediates inflammatory and angiogenic mechanisms
Connolly, M. C., Rooney, P., McGarry, T., Maratha, A., McCormick, J., Miggin, S. M., Veale, D. J., & Fearon, U. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207655 · Cited by 65
VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease
Mahajan, S., Hogan, J. K., Shlyakhter, D., Oh, L., Salituro, F. G., Farmer, L. J., & Hoock, T. C. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221176 · Cited by 64
Targeting non-canonical nuclear factor-κB signalling attenuates neovascularization in a novel 3D model of rheumatoid arthritis synovial angiogenesis
Maracle, C. X., Kucharzewska, P., Helder, B., van der Horst, C., de Sampaio, P. C., Noort, A.-R., van Zoest, K. P. M., Griffioen, A. W., Olsson, H., & Tas, S. W. (2016) · Lara D. Veeken · doi:10.1093/rheumatology/kew393 · Cited by 64
p ‐Coumaric acid, a dietary polyphenol ameliorates inflammation and curtails cartilage and bone erosion in the rheumatoid arthritis rat model
Neog, M. K., Pragasam, S. J., Krishnan, M., & Rasool, M. (2017) · BioFactors · doi:10.1002/biof.1377 · Cited by 66
“Its enigmatic pathogenesis is often characterized by cartilage degradation and bone erosion accompanied with pain and synovial inflammation [1].”
Background
Dual-functional lipid polymeric hybrid pH-responsive nanoparticles decorated with cell penetrating peptide and folate for therapy against rheumatoid arthritis
Zhao, J., Zhang, X., Sun, X., Zhao, M., Yu, C., Lee, R. J., Sun, F., Zhou, Y., Li, Y., & Teng, L. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.06.020 · Cited by 64
Cognitive impairment in patients with rheumatoid arthritis
Vitturi, B. K., Nascimento, B. A. C., Alves, B. R., de Campos, F. S. C., & Torigoe, D. Y. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.08.027 · Cited by 64
Critical Assessment of Pharmacokinetic Drug–Drug Interaction Potential of Tofacitinib, Baricitinib and Upadacitinib, the Three Approved Janus Kinase Inhibitors for Rheumatoid Arthritis Treatment
Veeravalli, V., Dash, R. P., Thomas, J. A., Babu, R. J., Madgula, L. M. V., & Srinivas, N. R. (2020) · Drug Safety · doi:10.1007/s40264-020-00938-z · Cited by 64
MiR-140-5p inhibits synovial fibroblasts proliferation and inflammatory cytokines secretion through targeting TLR4
Li, H., Guan, S., Lu, Y., & Wang, F. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.079 · Cited by 64
Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of U.S. Veterans
Natalini, J. G., Baker, J. F., Singh, N., Mahajan, T., Roul, P., Thiele, G. M., Sauer, B. C., Johnson, C. R., Kawut, S. M., Mikuls, T. R., et al. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202006-590oc · Cited by 63
Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets
Zheng, H., Liu, Y., Deng, Y., Li, Y., Liu, S., Yang, Y., Qiu, Y., Li, B., Sheng, W., Liu, J., et al. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00788-w · Cited by 69

Authors: McInnes, I. B., & Schett, G.
Affiliations: University of Glasgow (GB)
Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
ORCID: McInnes, Iain B.
Schett, Georg
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2011-12-08
Volume: 365
Issue: 23
Pages: 2205-2219
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra1004965
OpenAlex: W2110826367
Cited by: 5,514
References: 100
Citations by year: 2026: 313 · 2025: 415 · 2024: 439 · 2023: 443 · 2022: 469 · 2021: 493 · 2020: 465 · 2019: 409 · 2018: 399 · 2017: 394 · 2016: 379 · 2015: 300 · 2014: 276 · 2013: 204 · 2012: 111
FWCI: 27.90
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
Keywords: rheumatoid arthritis, pathogenesis, immune mechanisms, disease-modifying antirheumatic drugs, mortality reduction
MeSH terms: Arthritis, Rheumatoid, Humans, Antirheumatic Agents, Gene-Environment Interaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Pathogenesis of Rheumatoid Arthritis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks